Table 3 Subgroup analysis of postoperative outcomes
Subgroup analysis | No. of studies | WMD | 95%CI | p | Heterogeneity (I2) |
|---|---|---|---|---|---|
Normalization of total serum bilirubin (d) | |||||
Study design | |||||
RCT | 2 | 0.24 | -0.02, 0.49 | 0.07 | 34% |
Procedure | |||||
Endoscope | 3 | 0.23 | 0.07, 0.39 | 0.005 | 16% |
Postoperative hospitalization duration (d) | |||||
Study design | |||||
RCT | 2 | 0.18 | -0.07, 0.43 | 0.16 | 0% |
Cohort study | 2 | -1.52 | -7.46, 4.42 | 0.62 | 99% |
Procedure | |||||
Endoscope | 3 | 0.45 | -0.02, 0.92 | 0.60 | 72% |